StockData
Alcon Inc logo

Alcon Inc (ALC) company profile

ALCNYSEOphthalmic GoodsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Feb 24, 2026Score 7/30
$74.11+0.47 (+0.64%)

Close on Nov 17, 2026Market cap $36.12BP/E 37.4Yield –

About Alcon

Ophthalmic Goods, SIC 3851

Alcon develops, manufactures, and distributes eye care products through two primary divisions: Surgical and Vision Care. Its Surgical segment offers implantable intraocular lenses, surgical equipment, consumables, and diagnostic platforms for procedures treating conditions such as cataracts, glaucoma, vitreoretinal disorders, and refractive errors. The Vision Care segment supplies daily disposable, reusable, and color contact lenses, alongside ocular health remedies including dry eye solutions, allergy treatments, glaucoma therapies, and lens care items. The company serves eye care professionals, ophthalmic surgeons, clinics, and direct consumers worldwide.

The company operates across 56 countries and distributes its products to patients and consumers in over 140 countries and territories. Its global infrastructure includes 16 specialized manufacturing plants and approximately 45 interactive clinical training facilities. Corporate headquarters are situated in Geneva, Switzerland, with registered offices maintained in Fribourg, Switzerland.

Summary of the business section of Alcon's latest annual report, written by StockData.

Company profile

Company

Legal name
Alcon Inc
Founded
1945
Headquarters
Fort Worth, TX
Address
6201 South Freeway 76134
Phone
(817) 293-0450
Website
alcon.com
Employees
25,000, Dec 31, 2025
Industry
Ophthalmic Goods
Incorporated in
V8
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Fort Worth, Texas

Stock & identifiers

Ticker
ALC
Exchange
NYSE
IPO date
Apr 9, 2019
Shares outstanding
487M, Dec 31, 2025
Public float
$11.61B, Dec 31, 2010
Filer category
Large accelerated filer
SEC CIK
1167379
FIGI
BBG00NPWH832
Share class FIGI
BBG00NPWGYR0
EIN
98-0205094

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Alcon's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“We employ over 25,000 associates operating in 56 countries and serve consumers and patients in over 140 countries and territories.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?